Delivery Order SPE2DB24D2101-SPE2DB25FKNPY
- Not listed
- The Defense Logistics Agency awarded a $4,283.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This contract was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.94 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. No set-aside designation was applied to this award, demonstrating the contractor's...
- The Defense Logistics Agency awarded a $5,590.59 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Orencia 125 mg/ml syringes. This competitively awarded, firm fixed-price contract is not set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be executed from the contractor's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orencia 125 mg/mL syringes, valued at $3,701.46. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, with a contract ceiling value of $13,415.30. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Orencia 125 mg/ml syringes, valued at $15,917.19 with firm fixed pricing. This competitive award, which carries no set-aside designation, is classified as a delivery order under a larger contract vehicle and is scheduled for completion by August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Orencia 250 mg vials, a biologic immunosuppressant medication used primarily for rheumatoid arthritis treatment. This firm fixed price delivery order, valued at $6,942.46, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The award was placed with AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a $17,548.12 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $17,135.28 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price, competitively awarded contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is unencumbered by...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNPYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,567.64 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages its prime indefinite delivery vehicle with the Defense Logistics Agency to fulfill federal medical procurement requirements across multiple therapeutic domains. The company's contract portfolio with DLA encompasses a broad range of pharmaceutical products and medical supplies supporting military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Orencia, a biologic immunosuppressant medication used in rheumatoid arthritis treatment, exemplifies the vendor's role as a critical supplier within the federal medical supply chain serving the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 8/18/25 |